Sugi Predict

Sugi Predict / Compounds / SCHEMBL759030

SCHEMBL759030

SCHEMBL759030

COc1cccc(F)c1C(=O)Nc1ccn(Cc2ccc(Cl)cc2Cl)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STIM1 Q13586 2/20 0.54
▸ ORAI1 Q96D31 2/20 0.54
▸ ORAI3 Q9BRQ5 1/20 0.54
▸ NPSR1 Q6W5P4 6/20 0.53
▸ LMNA P02545 6/20 0.53
▸ GAA P10253 1/20 0.53
▸ SMN1; SMN2 Q16637 7/20 0.52
▸ HPGD P15428 2/20 0.52
▸ HTT P42858 2/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ ALDH1A1 P00352 4/20 0.50
▸ MAPT P10636 2/20 0.50
▸ STAT3 P40763 1/20 0.50
▸ PTGER1 P34995 3/20 0.48
▸ EGFR P00533 1/20 0.47
▸ NPC1 O15118 4/20 0.46
▸ RAB9A P51151 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL756310 0.92 PTGER1 (0.50) STIM1ORAI1ORAI3NPSR1LMNA
SCHEMBL30096611 0.90 STIM1 (0.64) STIM1ORAI1ORAI3NPSR1LMNA
SCHEMBL758257 0.90 STIM1 (0.64) STIM1ORAI1ORAI3NPSR1LMNA
SCHEMBL30096534 0.88 STIM1 (0.59) STIM1ORAI1ORAI3NPSR1LMNA
SCHEMBL755023 0.88 STIM1 (0.59) STIM1ORAI1ORAI3NPSR1LMNA
SCHEMBL758016 0.88 PTGER1 (0.57) STIM1ORAI1ORAI3NPSR1LMNA
SCHEMBL758268 0.86 STIM1 (0.59) STIM1ORAI1ORAI3NPSR1LMNA
SCHEMBL30096610 0.86 STIM1 (0.59) STIM1ORAI1ORAI3NPSR1LMNA
SCHEMBL759838 0.86 STIM1 (0.59) STIM1ORAI1ORAI3NPSR1LMNA
SCHEMBL30096545 0.83 SMN1; SMN2 (0.54) STIM1ORAI1ORAI3NPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399436-B2 N-pyrazolyl carboxamides as CRAC channel inhibitors GLAXO GROUP LIMITED (GB) 2013-03-19 — — US disclosed
US-8399436-B2 N-pyrazolyl carboxamides as CRAC channel inhibitors GLAXO GROUP LIMITED (GB) 2013-03-19 — — US disclosed
US-8399436-B2 N-pyrazolyl carboxamides as CRAC channel inhibitors GLAXO GROUP LIMITED (GB) 2013-03-19 — — US disclosed
US-20120053150-A1 N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INIHIBITORS GLAXO GROUP LIMITED (GB) 2012-03-01 — — US disclosed
US-20120053150-A1 N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INIHIBITORS GLAXO GROUP LIMITED (GB) 2012-03-01 — — US disclosed
US-20120053150-A1 N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INIHIBITORS GLAXO GROUP LIMITED (GB) 2012-03-01 — — US disclosed
WO-2010122089-A1 N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INHIBITORS GLAXO GROUP LIMITED (GB) 2010-10-28 — — WO disclosed
US-20100273744-A1 COMPOUNDS GORE PAUL MARTIN 2010-10-28 — — US disclosed
US-20100273744-A1 COMPOUNDS GORE PAUL MARTIN 2010-10-28 — — US disclosed
US-20100273744-A1 COMPOUNDS GORE PAUL MARTIN 2010-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053150-A1 N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INIHIBITORS ORAI1, TRPV1, CACNA1E STIM1 33/4885ORAI1 1/4885ORAI3 25/4885
US-20100273744-A1 COMPOUNDS LTC4S, HRH4, HRH2 STIM1 2564/4885ORAI1 3127/4885ORAI3 2440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.